SCHEMBL7670560

SCHEMBL7670560

COC(=O)c1cc(CS)cc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.52
ALDH1A1 P00352 5/20 0.52
HPGD P15428 4/20 0.52
NPSR1 Q6W5P4 1/20 0.52
MAPT P10636 4/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALOX12 P18054 1/20 0.44
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
MAPK8 P45983 1/20 0.42
MAPK9 P45984 1/20 0.42
MAPK10 P53779 1/20 0.42
NR4A2 P43354 3/20 0.42
TSHR P16473 2/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CREBBP Q92793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27747747 0.86 KDM4E (0.54) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL21822426 0.84 KDM4E (0.51) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1071793 0.84 KDM4E (0.51) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1110123 0.83 MAPT (0.44) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1072812 0.82 ALDH1A1 (0.50) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1074230 0.82 KDM4E (0.50) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1071765 0.80 KDM4E (0.48) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL1071701 0.79 MTNR1A (0.49) KDM4EALDH1A1HPGDNPSR1
SCHEMBL15936293 0.78 ALDH1A1 (0.58) KDM4EALDH1A1HPGDNPSR1MAPT
SCHEMBL5315678 0.78 KDM4E (0.58) KDM4EALDH1A1HPGDNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed